| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Mai―22 |
Onnamide A suppresses the severe acute respiratory syndrome-coronavirus 2 infection without inhibiting 3-chymotrypsin-like cysteine protease |
Yasuhiro Hayashi, Nanami Higa, Tetsuro Yoshida, Trianda Ayuning Tyas, Kanami Mori-Yasumoto, Mina Yasumoto-Hirose, et al. (+3) Hideki Tani, Junichi Tanaka, Takahiro Jomori |
| 2 |
[GO] |
2023―Mrz―08 |
Reactive oxygen species are associated with the inhibitory effect of N-(4-hydroxyphenyl)-retinamide on the entry of the severe acute respiratory syndrome-coronavirus 2 |
Yasuhiro Hayashi, Xuhao Huang, Takashi Tanikawa, Kazunari Tanigawa, Mizuki Yamamoto, Jin Gohda, et al. (+3) Jun-ichiro Inoue, Koichi Fukase, Kazuya Kabayama |
| 3 |
[GO] |
2023―Feb―07 |
Inhibition of SARS-CoV-2 nucleocapsid protein-RNA interaction by guanosine oligomeric RNA |
Ryoya Sekine, Satsuki Tsuno, Hayato Irokawa, Kazuhiro Sumitomo, Tianxue Han, Yusuke Sato, et al. (+3) Seiichi Nishizawa, Koki Takeda, Shusuke Kuge |
| 4 |
[GO] |
2022―Nov―22 |
Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant |
Keishi Yamaguchi, Itsuki Anzai, Ryota Maeda, Maiko Moriguchi, Tokiko Watanabe, Akihiro Imura, et al. (+2) Akifumi Takaori-Kondo, Tsuyoshi Inoue |
| 5 |
[GO] |
2022―Jul―06 |
Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry |
Katsutoshi Yoshizato, Toshio Taira, Misako Sato-Matsubara, Shizuko Sekiguchi, Yoriko Yabunaka, Yukimi Kira, et al. (+12) Tetsu Ohashi, Atsuko Daikoku, Ken Ofusa, Chiho Kadono, Daisuke Oikawa, Tsutomu Matsubara, Yu Nakagama, Yasutoshi Kido, Fuminori Tokunaga, Kazuo Ikeda, Akira Kaneko, Norifumi Kawada |
| 6 |
[GO] |
2021―Mrz―26 |
SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2 |
Anna A Kiseleva, Elizabeth M Troisi, Scott E Hensley, Rahul M Kohli, Jonathan A Epstein |
|
